The following is a list of studies of CAM therapies for HIV/AIDS and/or chronic hepatitis that are currently being conducted and which may also be seeking participants for enrollment. Please click on the study of interest to you for more information on contacting local hospitals.
FIAR has currently received NIH approval, working with Mt. Sinai Medical Center, to conduct two studies.
For more information on these and future studies, please contact us!
Other studies currently up and running are found below. If you know of a study currently enrolling that is not listed here, please contact us. Please also see the ACRIA and AIDS Research Alliance websites.
AIDS Research Alliance is conducting a study of "prostratin" which is derived from Homolanthus nutans from the Samoan rainforest. This is a joint project with the NIH National Cancer Institute. One remarkable aspect of the study is that it is following the "fair trade" principles that FIAR will adhere to: should the study show any benefit and there are commercial benefits, 20% will return to the Samoan people.
A study is being conducted at Columbia University Medical Center on 168th Street of Fish Oil Supplement and/or fenofibrate to help manage elevated triglycerides (above 400). You need to have been on antiretroviral therapy for at least the past three months. Contact Michele at 212-305-2201.
In Houston, Texas, a study of diet, exercise and medication is being undertaken to address high cholesterol (LDL), triglycerides called the Heart Positive Study.
In Vancouver, British Columbia, Canada, a study entitled L-Acetylcarnitine as Treatment of Antiretroviral-induced Peripheral Neuropathy is being conducted. The contact there is Jack DaSilva who may be reached at 604-806-8074. This information is listed on CATIE's website.
Another study in New York City of carnitine seeks to evaluate its effect in managing fatigue. Participants will receive increasing doses up to 3 grams per day over a period of only five weeks. There is some concern as to the rationale for evaluating carnitine for fatigue. Participants will be evaluated for carnitine deficiency; such patients will be eligible for the study. The study is being conducted by Beth Israel (click for specific information on the study).
DHEA study at Columbia University, Judith Rabkin, PI
Lactic Acidosis Study at the University of Michigan
Tufts University Research Studies
This list is obviously very short. Despite the fact that millions of people with HIV around the world rely on a wide range of botanicals to manage HIV, symptoms, infections and, increasingly for those who have access, the potentially fatal side effects of antiretroviral therapy. The U.S. government's so far dismal and grudging response to the enormous need for clinical data is one of the many reasons FIAR was formed. Yet, the growing list does show the increasing recognition of the need to undertake such studies. Activist involvement will be a major factor in assuring that the list grows to meet the needs of people with HIV/AIDS and other chronic diseases. And grows in such a way that it provides meaningful information that will help people the world over guide their treatment choices.